Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells

Molecular Cancer Research

Volumn 7, Issue 5, 2009, Pages 724-734

  Heakal, Yasser ^a   Kester, Mark ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTENSIN RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN SUBUNIT;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DRUG FORMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CERAMIDES; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; IMMUNOPRECIPITATION; LIPOSOMES; MEMBRANE MICRODOMAINS; MITOGEN-ACTIVATED PROTEIN KINASES; NANOTECHNOLOGY; NEUROTENSIN; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, NEUROTENSIN; TETRADECANOYLPHORBOL ACETATE;

EID: 66349120546     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0322     Document Type: Article

References (31)

1. Uhl GR, Snyder SH. Neurotensin receptor binding, regional and subcellular distributions favor transmitter role. Eur J Pharmacol 1977;41:89-91. (Pubitemid 8008357)
2. Kitabgi P, Freychet P. Neurotensin contracts the guinea-pig longitudinal ileal smooth muscle by inducing acetylcholine release. Eur J Pharmacol 1979;56:403-406 (Pubitemid 9202718)
3. Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 2006;27:2445-2460 (Pubitemid 44402788)
4. Vias M, Burtt G, Culig Z, Veerakumarasivam A, Neal DE, Mills IG. A role for neurotensin in bicalutamide resistant prostate cancer cells. Prostate 2007;67:190-202. (Pubitemid 46185322)
5. Seufferlein T, Rozengurt E. Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. Cancer Res 1996;56:5758-5764 (Pubitemid 26422185)
6. Evers BM. Neurotensin and growth of normal and neoplastic tissues. Peptides 2006;27:2424-2433 (Pubitemid 44429934)
7. Souaze F, Dupouy S, Viardot-Foucault V, et al. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression. Cancer Res 2006;66:6243-6249
8. Somai S, Gompel A, Rostene W, Forgez P. Neurotensin counteracts apoptosis in breast cancer cells. Biochem Biophys Res Commun 2002;295:482-488 (Pubitemid 34785860)
9. Quest AF, Leyton L, Parraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol 2004;82:129-144 (Pubitemid 38580879)
10. Schley PD, Brindley DN, Field CJ. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 2007;137:548-553 (Pubitemid 46397481)
11. London M, London E. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem 2004;279:9997-10004. (Pubitemid 38372602)
12. Gidwani A, Brown HA, Holowka D, Baird B. Disruption of lipid order by short-chain ceramides correlates with inhibition of phospholipase D and downstream signaling by FcεRI. J Cell Sci 2003;116:3177-3187 (Pubitemid 37038966)
13. Jacobson K, Mouritsen OG, Anderson RG. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 2007;9:7-14. (Pubitemid 46024188)
14. Barnett-Norris J, Lynch D, Reggio PH. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. Life Sci 2005;77:1625-1639 (Pubitemid 41073657)
15. Hajduch E, Turban S, Le LX, et al. Targeting of PKCζ and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Biochem J 2008;410:369-379
16. Fox TE, Houck KL, O'Neill SM, et al. Ceramide recruits and activates protein kinase Cζ (PKCζ) within structured membrane microdomains. J Biol Chem 2007;282:12450-12457 (Pubitemid 47100622)
17. Stover TC, Sharma A, Robertson GP, Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005;11:3465-3474 (Pubitemid 40627901)
18. Stover T, Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 2003;307:468-475 (Pubitemid 37310658)
19. Devalapally H, Duan Z, Seiden MV, Amiji MM. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int J Cancer 2007;121:1830-1838 (Pubitemid 47417304)
20. Insel PA, Head BP, Patel HH, Roth DM, Bundey RA, Swaney JS. Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. Biochem Soc Trans 2005;33:1131-1134 (Pubitemid 41659132)
21. Pelaprat D. Interactions between neurotensin receptors and G proteins. Peptides 2006;27:2476-2487 (Pubitemid 44425365)
22. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007;7:79-94. (Pubitemid 46164746)
23. McArdle CA, Franklin J, Green L, Hislop JN. The gonadotrophin-releasing hormone receptor: signalling, cycling and desensitisation. Arch Physiol Biochem 2002;110:113-122 (Pubitemid 34522887)
24. Morris DP, Lei B, Wu YX, Michelotti GA, Schwinn DA. The α1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits. J Biol Chem 2008;283:2973-2985
25. Xu W, Yoon SI, Huang P, et al. Localization of the κ opioid receptor in lipid rafts. J Pharmacol Exp Ther 2006;317:1295-1306 (Pubitemid 43764136)
26. Ishizaka N, Griendling KK, Lassegue B, Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 1998;32:459-466 (Pubitemid 28429134)
27. Yu C, Alterman M, Dobrowsky RT. Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1. J Lipid Res 2005;46:1678-1691 (Pubitemid 41099335)
28. Oh P, Schnitzer JE. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell 2001;12:685-698
29. Kester M, Heakal Y, Fox T, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 2008.
30. Boudin H, Lazaroff B, Bachelet CM, Pelaprat D, Rostene W, Beaudet A. Immunologic differentiation of two high-affinity neurotensin receptor isoforms in the developing rat brain. J Comp Neurol 2000;425:45-57. (Pubitemid 30620665)
31. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 1996;271:9690-9697 (Pubitemid 26137376)